(RS)-[3-[5-Methyl-2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]-1-piperidyl]-(4,5,6,7-tetrahydrobenzothiophen-2-yl)methanone

ID: ALA4780124

Chembl Id: CHEMBL4780124

PubChem CID: 162663071

Max Phase: Preclinical

Molecular Formula: C21H22F3N5OS

Molecular Weight: 449.50

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(C2CCCN(C(=O)c3cc4c(s3)CCCC4)C2)n2nc(C(F)(F)F)nc2n1

Standard InChI:  InChI=1S/C21H22F3N5OS/c1-12-9-15(29-20(25-12)26-19(27-29)21(22,23)24)14-6-4-8-28(11-14)18(30)17-10-13-5-2-3-7-16(13)31-17/h9-10,14H,2-8,11H2,1H3

Standard InChI Key:  AKRUQABJYHDWTQ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4780124

    ---

Associated Targets(Human)

PDE2A Tclin Phosphodiesterase 2A (1799 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pde10a cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (1396 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 449.50Molecular Weight (Monoisotopic): 449.1497AlogP: 4.41#Rotatable Bonds: 2
Polar Surface Area: 63.39Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.98CX LogD: 4.98
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.58Np Likeness Score: -2.11

References

1. Tresadern G,Velter I,Trabanco AA,Van den Keybus F,Macdonald GJ,Somers MVF,Vanhoof G,Leonard PM,Lamers MBAC,Van Roosbroeck YEM,Buijnsters PJJA.  (2020)  [1,2,4]Triazolo[1,5-a]pyrimidine Phosphodiesterase 2A Inhibitors: Structure and Free-Energy Perturbation-Guided Exploration.,  63  (21.0): [PMID:33105987] [10.1021/acs.jmedchem.0c01272]

Source